Neuro-feedback Therapy for Treating Tinnitus — TNTA  

Hearing Loss Clinical Trial

Official title: Neuro-feedback Therapy for Treating Tinnitus : Efficacy Pilot Study on a Targeted Population

Status Recruiting

Clinical Trial Summary

Neuro-feedback for treating tinnitus seem to be a promising approach to help people suffering from chronic tinnitus. The past studies on this approach suffered interindividual variability in their results. The investigators' current hypothesis is that the variability of the results is the consequences of two possible flaws: lack of appropriate patient selection and lack of support of the patient during the therapy. This study is aimed at testing these hypotheses.

Clinical Trial Description

Many individuals with tinnitus have abnormal oscillatory brain activity in their temporal areas (Weisz et al. (2005), Schlee et al. (2014)). Led by this finding, attempts to normalize such localized pathological activity by neuro-feedback techniques have been tested (Dohrmann et al. (2007), Gütenspenger et al. (2017)). These attempts highlighted interindividual variability that can be explained by lack of selection of the patient population and lack of guidance through the therapy. The present study is aimed at addressing these issues by choosing more selectively a patient subpopulation (tinnitus associated with moderate hearing loss) and by implementing a guidance interface during the treatment.

The therapy will consist of 10 neuro-feedback training sessions of 29 minutes over 5 weeks. Each session will be composed of 6 blocks of 3 min in which the patient will be incited to practise a specific cognitive strategy (mental exercise such as "think to a music you like") and resting state measurements.

Each patient who has been recruited to fit our inclusion and non-inclusion criteria will first go through a clinical assessment of his initial judgment criteria metrics. Then subjects will go through the 5-week training and then will be evaluated on the same criteria just after the end of the therapy and at 3 months after the end of it. ;

Related Conditions & MeSH terms

• Hearing Loss
• Tinnitus

• NCT number: NCT03773926
• Study type: Interventional
• Source: Zeta Technologies
• Contact: Alain LONDERO
• Phone: 05 61 77 21 19
• Email: Alain.londero@aphp.fr
• Status: Recruiting
• Phase: N/A
• Start date: May 28, 2018
• Completion date: January 15, 2019